Optimizing an immunomodulatory potency assay for Mesenchymal Stromal Cell.
Ontology highlight
ABSTRACT: The expeditious progress of Mesenchymal Stromal Cells (MSC) for therapeutic intervention calls for means to compare differences in potency of cell products. The differences may be attributed to innumerable sources including tissue origin, production methods, or even between batches. While the immunomodulatory potential of MSC is recognized and well-documented by an expansive body of evidence, the methodologies and findings vary markedly. In this study, we utilized flowcytometric analysis of lymphocyte proliferation based on cryopreserved peripheral blood mononuclear cells for quantification of the inhibitory effect of MSC. Technical aspects of fluorescent staining and cryopreservation of peripheral blood mononuclear cells were evaluated to obtain optimal results and increase feasibility. A
SUBMITTER: Hansen SB
PROVIDER: S-EPMC9791065 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA